Your browser doesn't support javascript.
loading
Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.
Hoornenborg, Elske; Prins, Maria; Achterbergh, Roel C A; Woittiez, Lycke R; Cornelissen, Marion; Jurriaans, Suzanne; Kootstra, Neeltje A; Anderson, Peter L; Reiss, Peter; de Vries, Henry J C; Prins, Jan M; de Bree, Godelieve J.
Afiliação
  • Hoornenborg E; Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, Netherlands; Department of Infectious Diseases, Clinic for Sexually Transmitted Infections, Public Health Service of Amsterdam, Amsterdam, Netherlands. Electronic address: ehoornenborg@ggd.amst
  • Prins M; Department of Infectious Diseases, Amsterdam Infection and Immunity Institute (AI&II), Academic Medical Center, University of Amsterdam, Netherlands.
  • Achterbergh RCA; Department of Infectious Diseases, Clinic for Sexually Transmitted Infections, Public Health Service of Amsterdam, Amsterdam, Netherlands.
  • Woittiez LR; Department of Infectious Diseases, Amsterdam Infection and Immunity Institute (AI&II), Academic Medical Center, University of Amsterdam, Netherlands.
  • Cornelissen M; Department of Medical Microbiology, Experimental Virology, Academic Medical Center, University of Amsterdam, Netherlands.
  • Jurriaans S; Department of Medical Microbiology, Clinical Virology, Academic Medical Center, University of Amsterdam, Netherlands.
  • Kootstra NA; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Netherlands.
  • Anderson PL; Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Reiss P; Department of Infectious Diseases, Amsterdam Infection and Immunity Institute (AI&II), Academic Medical Center, University of Amsterdam, Netherlands; Department of Global Health and Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Netherlan
  • de Vries HJC; Department of Infectious Diseases, Amsterdam Infection and Immunity Institute (AI&II), Academic Medical Center, University of Amsterdam, Netherlands; Department of Dermatology, Academic Medical Center, University of Amsterdam, Netherlands; National Institute of Public Health and the Environment,
  • Prins JM; Department of Infectious Diseases, Amsterdam Infection and Immunity Institute (AI&II), Academic Medical Center, University of Amsterdam, Netherlands.
  • de Bree GJ; Department of Infectious Diseases, Amsterdam Infection and Immunity Institute (AI&II), Academic Medical Center, University of Amsterdam, Netherlands; Department of Global Health and Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Netherlan
Lancet HIV ; 4(11): e522-e528, 2017 11.
Article em En | MEDLINE | ID: mdl-28919303
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Organofosfatos / Adenina / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Profilaxia Pré-Exposição Tipo de estudo: Diagnostic_studies Idioma: En Revista: Lancet HIV Ano de publicação: 2017 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Organofosfatos / Adenina / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Profilaxia Pré-Exposição Tipo de estudo: Diagnostic_studies Idioma: En Revista: Lancet HIV Ano de publicação: 2017 Tipo de documento: Article País de publicação: Holanda